Hazel J. Dyke

1.3k citations

30 papers · 911 indexed · h-index 20

Co-authors: John G. Montana Nicholas C. Ray Peter Lockey David E. Clark Melanie Wong Alan G. Roach Dennis Norman Eric J. Thomas
Topics: Phosphodiesterase function and regulation (11 papers)Receptor Mechanisms and Signaling (8 papers)Cholinesterase and Neurodegenerative Diseases (6 papers)
Cited by: Organic Chemistry Endocrine and Autonomic Systems Pharmacology
Journals: Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics The Journal of Organic Chemistry
Partner nations: United Kingdom United States Australia

In The Last Decade

Hazel J. Dyke

30 papers receiving 844 citations

Peers

Countries citing papers authored by Hazel J. Dyke

Since Specialization

Citations

This map shows the geographic impact of Hazel J. Dyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel J. Dyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel J. Dyke more than expected).

Fields of papers citing papers by Hazel J. Dyke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazel J. Dyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel J. Dyke. The network helps show where Hazel J. Dyke may publish in the future.

Co-authorship network of co-authors of Hazel J. Dyke

This figure shows the co-authorship network connecting the top 25 collaborators of Hazel J. Dyke. A scholar is included among the top collaborators of Hazel J. Dyke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazel J. Dyke. Hazel J. Dyke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modulation of 11β-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles 2010 ·Bioorganic & Medicinal Chemistry Letters ·Scott P. Webster,Margaret Binnie,(unknown),Karen Sooy,Peter Ward,Michael F. Greaney,Andy Vinter,T. David Pallin,Hazel J. Dyke,(unknown),(unknown),Jonathan R. Seckl,Brian R. Walker	22
2	1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity 2008 ·Bioorganic & Medicinal Chemistry Letters ·Robin D. Clark,Nicholas C. Ray,Karen Williams,Paul Blaney,Stuart D.C. Ward,Peter H. Crackett,Christopher A. Hurley,Hazel J. Dyke,David E. Clark,Peter Lockey,René Devos,Melanie Wong,(unknown),(unknown),Robert E. Jenkins,Joseph K. Belanoff	40
3	Novel 5,6-dihydropyrazolo-[3,4-E][1,4]diazepin-4 (1H)-one derivatives for the treatment of asthma and chronic obstructive pulmonary disease 2007 ·Expert Opinion on Therapeutic Patents ·Hazel J. Dyke	6
4	Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators 2007 ·Bioorganic & Medicinal Chemistry Letters ·Nicholas C. Ray,Robin D. Clark,David E. Clark,Karen Williams,(unknown),Peter H. Crackett,Hazel J. Dyke,Peter Lockey,Melanie Wong,René Devos,(unknown),Joseph K. Belanoff	24
5	2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Robin D. Clark,Nicholas C. Ray,Paul Blaney,Peter H. Crackett,Christopher A. Hurley,Karen Williams,Hazel J. Dyke,David E. Clark,Peter Lockey,René Devos,Melanie Wong,(unknown),Joseph K. Belanoff	7
6	Quinazoline and benzimidazole MCH-1R antagonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Hazel J. Dyke,Peter Lockey,Dennis Norman,Alan G. Roach,(unknown),Melanie Wong,Stephen P. Wren	17
7	Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Helen L. Birch,George M. Buckley,(unknown),Hazel J. Dyke,(unknown),(unknown),(unknown),Alan F. Haughan,(unknown),Trevor Morgan,William R. Pitt,Andrew J. Ratcliffe,Nicholas C. Ray,(unknown),Andrew Sharpe,(unknown),(unknown),(unknown)	50
8	Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure–activity relationships 2004 ·Bioorganic & Medicinal Chemistry Letters ·George M. Buckley,(unknown),Hazel J. Dyke,(unknown),(unknown),Alan F. Haughan,(unknown),William R. Pitt,(unknown),Nicholas C. Ray,(unknown),Andrew Sharpe,(unknown),(unknown),(unknown)	46
9	Structure–activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),David E. Clark,(unknown),(unknown),Hazel J. Dyke,Peter Lockey,Dennis Norman,Alan G. Roach,(unknown),(unknown),Melanie Wong,Stephen P. Wren	36
10	8-Methoxyquinolines as PDE4 inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·Motasim Billah,George M. Buckley,Nicola J. Cooper,Hazel J. Dyke,Robert W. Egan,Ashit K. Ganguly,Lewis Gowers,Alan F. Haughan,(unknown),Christopher Lowe,Michael Minnicozzi,John G. Montana,Janet Oxford,(unknown),(unknown),John J. Piwinski,Robert J. Naylor,Verity Sabin,Neng‐Yang Shih,J.B.H. Warneck	18
11	Update on the therapeutic potential of PDE4 inhibitors 2002 ·Expert Opinion on Investigational Drugs ·John G. Montana,Hazel J. Dyke	155
12	8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma 2002 ·Bioorganic & Medicinal Chemistry Letters ·George M. Buckley,Nicola Cooper,Hazel J. Dyke,(unknown),Lewis Gowers,Alan F. Haughan,(unknown),Christopher Lowe,(unknown),John G. Montana,Robert J. Naylor,Janet Oxford,(unknown),(unknown),(unknown),Verity Sabin,Andrew Sharpe,J.B.H. Warneck	12
13	7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 Inhibitors: A Potential Treatment for Asthma 2002 ·Bioorganic & Medicinal Chemistry Letters ·George M. Buckley,Nicola J. Cooper,Richard Davenport,Hazel J. Dyke,(unknown),Lewis Gowers,Alan F. Haughan,(unknown),Christopher Lowe,John G. Montana,Janet Oxford,(unknown),(unknown),(unknown),Verity Sabin,Andrew Sharpe,J.B.H. Warneck	17
14	Pharmacology of N-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline Carboxamide (SCH 351591), a Novel, Orally Active Phosphodiesterase 4 Inhibitor 2002 ·Journal of Pharmacology and Experimental Therapeutics ·M. Motasim Billah,Nicola J. Cooper,Michael Minnicozzi,J.B.H. Warneck,Peng Wang,John A. Hey,William Kreutner,Charles A. Rizzo,Sidney R. Smith,Simon Young,Richard W. Chapman,Hazel J. Dyke,(unknown),John J. Piwinski,Francis M. Cuss,John G. Montana,Ashit K. Ganguly,Robert W. Egan	27
15	Synthesis and structure–activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Michael R. Barnes,Nicola Cooper,Richard Davenport,Hazel J. Dyke,(unknown),F Galvin,Lewis Gowers,Alan F. Haughan,Christopher Lowe,Johannes Meissner,(unknown),Trevor Morgan,(unknown),Robert J. Watson	39
16	Maximal airway pressures during crying in healthy preterm and term neonates 2000 ·Early Human Development ·Gabriel Dimitriou,Anne Greenough,Hazel J. Dyke,Gerrard F. Rafferty	29
17	7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma 2000 ·Bioorganic & Medicinal Chemistry Letters ·George M. Buckley,Nicola Cooper,Hazel J. Dyke,(unknown),Lewis Gowers,(unknown),(unknown),Alan F. Haughan,Paul G. Hellewell,(unknown),Christopher Lowe,(unknown),John G. Montana,Robert J. Naylor,(unknown),(unknown),Verity Sabin,B. R. Tuladhar,J.B.H. Warneck	15
18	The therapeutic potential of PDE4 inhibitors 1999 ·Expert Opinion on Investigational Drugs ·Hazel J. Dyke,John G. Montana	33
19	PDE4 inhibitors: New xanthine analogues 1998 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Nicola Cooper,Hazel J. Dyke,Lewis Gowers,(unknown),Paul G. Hellewell,Jadwiga M. Miotla,(unknown),Robert J. Naylor,B. R. Tuladhar,J.B.H. Warneck	7
20	Aryl sulfonamides as selective PDE4 inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·John G. Montana,George M. Buckley,Nicola Cooper,Hazel J. Dyke,Lewis Gowers,(unknown),Paul G. Hellewell,(unknown),Christopher Lowe,(unknown),Jadwiga M. Miotla,Robert J. Naylor,(unknown),B. R. Tuladhar,J.B.H. Warneck	19

About Hazel J. Dyke

Hazel J. Dyke is a scholar working on Physiology, Endocrine and Autonomic Systems and Pharmacology, having authored 30 papers that have together received 911 indexed citations. Recurring topics across this work include Phosphodiesterase function and regulation (11 papers), Receptor Mechanisms and Signaling (8 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). The work is most often cited by research in Organic Chemistry (382 citations), Endocrine and Autonomic Systems (69 citations) and Pharmacology (170 citations). Hazel J. Dyke has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include John G. Montana, Nicholas C. Ray, Peter Lockey, David E. Clark, Melanie Wong, Alan G. Roach, Dennis Norman, Eric J. Thomas, Stephen P. Wren and Harold W. Moore. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact